CoChat
Sign Up
Cited by 456Cardiovascular Health and Disease PreventionNitric Oxide and Endothelin EffectsMitochondrial Function and Pathology

The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.

Chronic Supplementation With a Mitochondrial Antioxidant (MitoQ) Improves Vascular Function in Healthy Older Adults

Open access
Rossman, Matthew J., Santos-Parker, Jessica R., Steward, Chelsea A.C., Bispham, Nina Z., Cuevas, Lauren M., Rosenberg, Hannah L., Woodward, Kayla A., Chonchol, Michel, Gioscia-Ryan, Rachel A., Murphy, Michael P., Seals, Douglas R.·2018·Hypertension
DOI 10.1161/hypertensionaha.117.10787PMC PMC5945293
Open this paper in CoChat — free accountOpen PDF

Abstract

Excess reactive oxygen species production by mitochondria is a key mechanism of age-related vascular dysfunction. Our laboratory has shown that supplementation with the mitochondrial-targeted antioxidant MitoQ improves vascular endothelial function by reducing mitochondrial reactive oxygen species and ameliorates arterial stiffening in old mice, but the effects in humans are unknown. Here, we sought to translate our preclinical findings to humans and determine the safety and efficacy of MitoQ. Twenty healthy older adults (60–79 years) with impaired endothelial function (brachial artery flow–mediated dilation <6%) underwent 6 weeks of oral supplementation with MitoQ (20 mg/d) or placebo in a randomized, placebo-controlled, double-blind, crossover design study. MitoQ was well tolerated, and plasma MitoQ was higher after the treatment versus placebo period ( P <0.05). Brachial artery flow–mediated dilation was 42% higher after MitoQ versus placebo ( P <0.05); the improvement was associated with amelioration of mitochondrial reactive oxygen species–related suppression of endothelial function (assessed as the increase in flow-mediated dilation with acute, supratherapeutic MitoQ [160 mg] administration; n=9; P <0.05). Aortic stiffness (carotid–femoral pulse wave velocity) was lower after MitoQ versus placebo ( P <0.05) in participants with elevated baseline levels (carotid–femoral pulse wave velocity >7.60 m/s; n=11). Plasma oxidized LDL (low-density lipoprotein), a marker of oxidative stress, also was lower after MitoQ versus placebo ( P <0.05). Participant characteristics, endothelium-independent dilation (sublingual nitroglycerin), and circulating markers of inflammation were not different (all P >0.1). These findings in humans extend earlier preclinical observations and suggest that MitoQ and other therapeutic strategies targeting mitochondrial reactive oxygen species may hold promise for treating age-related vascular dysfunction. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT02597023.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.117.10787

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

Sorted by citations

Items 401–456 of 456

Related

See all

Metadata

Authors
Rossman, M. J., Santos-Parker, J. R., Steward, C. A. C., Bispham, N. Z., Cuevas, L. M., Rosenberg, H. L., Woodward, K. A., Chonchol, M., Gioscia-Ryan, R. A., Murphy, M. P., & Seals, D. R.
Affiliations
  • University of Colorado Boulder (US)
  • From the Department of Integrative Physiology, University of Colorado Boulder (M.J.R., J.R.S.-P., C.A.C.S., N.Z.B., L.M.C., H.L.R., K.A.W., R.A.G.-R., D.R.S.)
  • University of Colorado Anschutz (US)
  • MRC Mitochondrial Biology Unit (GB)
ORCID
Venue
Hypertension
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2018-06
Volume
71
Issue
6
Pages
1056-1063
ISSN
  • 0194-911X (ISSN-L)
  • 1524-4563
DOI
10.1161/hypertensionaha.117.10787
PMC
PMC5945293
OpenAlex
W2796629168
Cited by
456
References
42
Citations by year
2026: 71 · 2025: 48 · 2024: 55 · 2023: 54 · 2022: 65 · 2021: 54 · 2020: 58 · 2019: 38 · 2018: 12
FWCI
30.51
Type
journal article
Language
en
Open access
Locations
  • Hypertension (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Apollo (University of Cambridge) (submittedVersion)
  • Apollo
Funders
  • Wellcome Trust (110158/Z/15/Z, 110159/Z/ 15/Z, /Z/15/Z)
  • Georgia Clinical and Translational Science Alliance (UL1TR001082)
  • National Institutes of Health (UL1TR001082, AG000279)
  • University of Colorado Boulder (UL1 TR001082)
  • Medical Research Council (MC_UU_00015/3, MC-U105663142)
  • National Institute on Aging (R21AG049451, F32AG053009, T32AG000279)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK048520)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
Keywords
MitoQ, mitochondria-targeted antioxidants, mitochondrial reactive oxygen species, endothelial function, flow-mediated dilation, arterial stiffness, pulse wave velocity, oxidative stress, oxidized LDL, aging, older adults, vascular dysfunction, dietary supplementation
MeSH terms
Aged, Antioxidants, Brachial Artery, Double-Blind Method, Endothelium, Vascular, Female, Follow-Up Studies, Humans, Male, Middle Aged, Mitochondria, Vasodilation, Reactive Oxygen Species, Oxidative Stress, Cross-Over Studies, Dietary Supplements, Vascular Stiffness, Healthy Volunteers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review